Article info
PostScript
Letter
Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review
- Correspondence to Dr David Giannandrea, Gubbio and Gualdo Tadino Hospital, Largo Unità d’Italia, Perugia 06024, Italy; david.giannandrea{at}uslumbria1.it
Citation
Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review
Publication history
- Received May 10, 2018
- Revised June 11, 2018
- Accepted June 26, 2018
- First published July 21, 2018.
Online issue publication
April 11, 2019
Article Versions
- Previous version (21 July 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.